In addition, growing evidence suggests SHP as a tumor suppressor [27] in hepatocellular carcinoma (HCC) by inhibiting hepatocyte proliferation [28], activating apoptosis [29], and repressing the expression of DNA methyltransferase [30], [31]. Here, NR0B2 is linked to neoplasm.